reviewNature Reviews Drug DiscoveryJul 31, 2015Closed access

Combination cancer immunotherapy and new immunomodulatory targets

KMKathleen M. MahoneyPDPaul D. RennertGJGordon J. Freeman

Harvard University · Dana-Farber Cancer Institute

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,330
total citations
FWCI
63.36
Percentile
100%
References
280
Citations per year

Authors

3

Topics & keywords

Topics
Keywords
  • Immune system
  • Immunotherapy
  • Stromal cell
  • Tumor microenvironment
  • Cancer research
  • Cytotoxic T cell
  • Immune checkpoint
  • Blockade
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.